Related Experiment Video
Updated: May 31, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells
Saima Muzaffar1, Jamie Y Jeremy, Gianni D Angelini
1Bristol Heart Institute, University of Bristol, Bristol, UK.
Abstract:
The protective actions of prostacyclin (PGI(2) ) are mediated by cyclic AMP (cAMP) which is reduced by type 4 phosphodiesterases (PDE4) which hydrolyze cAMP. Superoxide (O2(-)) from NADPH oxidase (Nox) is associated with impaired PGI(2) bioactivity. The objective of this study, therefore, was to study the relationship between Nox and PDE4 expression in human umbilical vein endothelial cells (HUVECs). HUVECs were incubated with the thromboxane A(2) analog, U46619, 8-isoprostane F(2α) (8IP), or tumor necrosing factor alpha (TNFα) [±iloprost (a PGI(2) analog)] and the expression of PDE4A, B, C, and D and splice variants thereof assessed using Western blotting and qPCR and mRNA silencing of Nox4 and Nox5. Effects on cell replication and angiogenesis were also studied. U46619, 8IP, and TNFα increased the expression of Nox 4 and Nox 5 and all PDE4 isoforms as well as cell replication and tubule formation (index of angiogenesis), effects inhibited by mRNA silencing of Nox4 (but not Nox5) and iloprost and rolipram. These data demonstrate that upregulation of Nox4 leads to an upregulation of PDE4A, B, and D and increased hydrolysis of cAMP which in turn augments cell replication and angiogenesis. This mechanism may be central to vasculopathies associated with endothelial dysfunction since the PGI(2)-cAMP signaling axis plays a key role in mediating functions that include hemostasis and angiogenesis.
Insights
NADPH oxidase (Nox) upregulation increases type 4 phosphodiesterases (PDE4), reducing cyclic AMP (cAMP) and promoting endothelial cell replication and angiogenesis. This Nox4-PDE4 pathway impacts vascular dysfunction.
Area of Science:
- Endothelial Cell Biology
- Vascular Biology
- Biochemistry
Background:
- Prostacyclin (PGI2) signaling, mediated by cyclic AMP (cAMP), is crucial for endothelial function.
- Type 4 phosphodiesterases (PDE4) hydrolyze cAMP, reducing PGI2's protective effects.
- NADPH oxidase (Nox)-derived superoxide is linked to impaired PGI2 bioactivity.
Purpose of the Study:
- To investigate the relationship between Nox and PDE4 expression in human umbilical vein endothelial cells (HUVECs).
- To determine the role of Nox4 and Nox5 in regulating PDE4 expression and endothelial cell functions.
Main Methods:
- HUVECs were treated with U46619, 8-isoprostane F2α, or TNFα, with or without iloprost.
- Expression of PDE4 isoforms (A, B, C, D) and Nox4/Nox5 was assessed via Western blotting and qPCR.
- mRNA silencing of Nox4 and Nox5 was employed to study their functional roles.
- Effects on cell replication and angiogenesis (tubule formation) were evaluated.
Main Results:
- U46619, 8IP, and TNFα increased Nox4, Nox5, and all PDE4 isoform expression.
- These stimuli also enhanced cell replication and tubule formation.
- mRNA silencing of Nox4, but not Nox5, inhibited these increases.
- Iloprost and rolipram (a PDE4 inhibitor) also reversed the effects.
Conclusions:
- Upregulation of Nox4 leads to increased expression of PDE4A, B, and D, augmenting cAMP hydrolysis.
- This mechanism enhances endothelial cell replication and angiogenesis, contributing to vasculopathies.
- The PGI2-cAMP signaling axis, modulated by Nox4 and PDE4, is central to endothelial dysfunction in vascular diseases.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antihypertensive Drugs: Vasodilators
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

